These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3553909

  • 1. [Intracellular proteolytic cleavage of the influenza virus protein NP as a sign of the epidemicity of virus strains?].
    Zhirnov OP.
    Mol Gen Mikrobiol Virusol; 1987 Feb; (2):35-9. PubMed ID: 3553909
    [Abstract] [Full Text] [Related]

  • 2. Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells.
    Zhirnov O, Bukrinskaya AG.
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1127-34. PubMed ID: 6374032
    [Abstract] [Full Text] [Related]

  • 3. Avian and human influenza a virus strains possess different intracellular nucleoprotein oligomerization efficiency.
    Prokudina EN, Semenova NP, Rudneva IA, Chumakov VM, Yamnikova SS.
    Acta Virol; 2001 Jun; 45(4):201-7. PubMed ID: 11885926
    [Abstract] [Full Text] [Related]

  • 4. [Proteolytic cleavage of influenza virus A protein NP characteristic of the strains of human origin detected in various strains isolated from animals].
    Zhirnov OP, Kras'ko AG, Iamnikova SS, Bukrinskaia AG, L'vov DK.
    Mol Gen Mikrobiol Virusol; 1986 Feb; (2):32-5. PubMed ID: 3537759
    [No Abstract] [Full Text] [Related]

  • 5. [Characterization of proteolytic cleavage of influenza virus nucleocapsid protein NP in infected cells].
    Zhirnov OP, Konakova TE, Garten W, Klenk HD.
    Vopr Virusol; 1999 Feb; 44(6):275-9. PubMed ID: 10665065
    [Abstract] [Full Text] [Related]

  • 6. [Difference in influenza virus strains in the intensity of the proteolytic modification of the base nucleocapsid protein NP56 to NP53 in infected cells].
    Zhirnov OP, Bukrinskaia AG.
    Vopr Virusol; 1983 Feb; (3):273-8. PubMed ID: 6351439
    [Abstract] [Full Text] [Related]

  • 7. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
    Zhirnov OP, Klenk HD.
    Virology; 2009 Nov 10; 394(1):57-63. PubMed ID: 19747708
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Complete oligomerization of the nucleoprotein and various strains of influenza virus].
    Semenova NP, Prokudina EN, Chumakov VM.
    Mol Gen Mikrobiol Virusol; 1996 Nov 10; (3):11-6. PubMed ID: 8999311
    [Abstract] [Full Text] [Related]

  • 10. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.
    Lipatov AS, Yen HL, Salomon R, Ozaki H, Hoffmann E, Webster RG.
    Arch Virol; 2008 Nov 10; 153(3):427-34. PubMed ID: 18058063
    [Abstract] [Full Text] [Related]

  • 11. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 10; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 12. An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003.
    Barr IG, Komadina N, Hurt AC, Iannello P, Tomasov C, Shaw R, Durrant C, Sjogren H, Hampson AW.
    J Med Virol; 2005 Jul 10; 76(3):391-7. PubMed ID: 15902711
    [Abstract] [Full Text] [Related]

  • 13. [Preparative isolation of basic structural proteins of the influenza virus].
    Ksenofontov AL, Fedorova NV, Glushakova SE.
    Mol Gen Mikrobiol Virusol; 1992 Jul 10; (3-4):3-6. PubMed ID: 1406760
    [Abstract] [Full Text] [Related]

  • 14. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ, Rhodes J, Liew FY, Tite JP.
    J Immunol; 1993 Apr 01; 150(7):2869-84. PubMed ID: 7681081
    [Abstract] [Full Text] [Related]

  • 15. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus.
    Saha S, Yoshida S, Ohba K, Matsui K, Matsuda T, Takeshita F, Umeda K, Tamura Y, Okuda K, Klinman D, Xin KQ, Okuda K.
    Virology; 2006 Oct 10; 354(1):48-57. PubMed ID: 16945400
    [Abstract] [Full Text] [Related]

  • 16. Intracellular oligomerization of influenza virus nucleoprotein.
    Prokudina-Kantorovich EN, Semenova NP.
    Virology; 1996 Sep 01; 223(1):51-6. PubMed ID: 8806539
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ.
    J Immunol; 1999 Apr 01; 162(7):4163-70. PubMed ID: 10201942
    [Abstract] [Full Text] [Related]

  • 19. Non-compact nucleocapsid protein multimers in influenza-virus-infected cells.
    Prokudina EN, Semenova NP, Chumakov VM, Grigorieva TA.
    Arch Virol; 2007 Apr 01; 152(5):981-8. PubMed ID: 17216139
    [Abstract] [Full Text] [Related]

  • 20. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H, Jin M, Yu Z, Xu X, Peng Y, Wu H, Liu J, Liu H, Cao S, Chen H.
    Antiviral Res; 2007 Nov 01; 76(2):186-93. PubMed ID: 17719657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.